References
- 1. Glushakova O, Glushakov A, Miller E, Valadka A, Hayes R. Biomarkers for acute diagnosis and management of stroke in neurointensive care units. Brain Circ. 2016;2(1):28. DOI: 10.4103/2394-8108.17854610.4103/2394-8108.178546
- 2. Hjalmarsson C, Bjerke M, Andersson B, Blennow K, Zetterberg H, Åberg ND, et al. Neuronal and Glia-Related Biomarkers in Cerebrospinal Fluid of Patients with Acute Ischemic Stroke. J Cent Nerv Syst Dis. 2014;6:51. DOI: 10.4137/JCNSD.S1382110.4137/JCNSD.S13821
- 3. Ungureanu D, Iencean ŞM, Dimitriu C, Iencean AŞ, Tascu A. Determination of the phosphorylated neurofilament subunit NF-H (pNF-H) in cerebro-spinal fluid as biomarker in acute traumatic spinal cord injuries. Rev Rom Med Lab. 2014;22(3):377-86.
- 4. Shaw G. Chapter 21 The Use and Potential of pNF-H as a General Blood Biomarker of Axonal. Brain Neurotrauma Mol Neuropsychol Rehabil Asp. 2015;1-17.
- 5. Petzold A. Neurofilament phosphoforms: Surrogate markers for axonal injury, degeneration and loss. J Neurol Sci. 2005;233(1):183-98. DOI: 10.1016/j.jns.2005.03.01510.1016/j.jns.2005.03.015
- 6. Clark WM, Rinker LG, Lessov NS, Hazel K, Eckenstein F. Time course of IL-6 expression in experimental CNS ischemia. Neurol Res. 1999;21(3):287-92. DOI: 10.1080/01616412.1999.1174093310.1080/01616412.1999.11740933
- 7. Adams HP, Bendixen BH, Kappelle LJ, Biller J, Love BB, Gordon DL, et al. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke. 1993 ;24(1):35-41. DOI: 10.1161/01.STR.24.1.3510.1161/01.STR.24.1.35
- 8. Shibahashi K, Doi T, Tanaka S, Hoda H, Chikuda H, Sawada Y, et al. The Serum Phosphorylated Neurofilament Heavy Subunit as a Predictive Marker for Outcome in Adult Patients after Traumatic Brain Injury. J Neurotrauma. 2016;33(20):1826-33. DOI: 10.1089/neu.2015.4237
- 9. Žurek J, Bartlová L, Fedora M. Hyperphosphorylated neurofilament NF-H as a predictor of mortality after brain injury in children. Brain Inj. 2011;25(2):221-6. DOI: 10.3109/02699052.2010.54189510.3109/02699052.2010.541895
- 10. Cai JY, Lu C, Chen MH, Ba HJ, Chen XD, Lin JH, et al. Predictive value of phosphorylated axonal neurofilament subunit H for clinical outcome in patients with acute intracerebral hemorrhage. Clin Chim Acta. 2013;424:182-6. DOI: 10.1016/j.cca.2013.06.019
- 11. Traenka C, Disanto G, Seiffge DJ, Gensicke H, Hert L, Grond-Ginsbach C, et al. Serum Neurofilament Light Chain Levels Are Associated with Clinical Characteristics and Outcome in Patients with Cervical Artery Dissection. Cerebrovasc Dis. 2015;40(5-6):222-7. DOI: 10.1159/00044077410.1159/000440774
- 12. Radwan WM, Rabbah AM, Saber H, Elghonemi MO. A new marker for ischemic cerebrovascular stroke: Phosphorylated Neurofilament H. Egypt J Crit Care Med. 2013;1(2):105-8. DOI: 10.1016/j.ejccm.2013.03.004
- 13. Singh P, Yan J, Hull R, Read SJ, O’Sullivan J, Henderson RD, et al. Levels of phosphorylated axonal neurofilament subunit H (pNfH) are increased in acute ischemic stroke. J Neurol Sci. 2011;304(1-2):117-21. DOI: 10.1016/j.jns.2011.01.02510.1016/j.jns.2011.01.025
- 14. Kim J-S, Lee K-B, Roh H, Ahn M-Y, Hwang H-W. Gender Differences in the Functional Recovery after Acute Stroke. J Clin Neurol. 2010;6(4):183. DOI: 10.3988/jcn.2010.6.4.18310.3988/jcn.2010.6.4.183